Endo Pharmaceuticals To Acquire HealthTronics
Endo Pharmaceuticals announced that it has signed an agreement to acquire HealthTronics Inc, a provider of urological products and services.
Read MoreSearch Results for: prostate cancer
Automation Trends and Products
Increasing costs and a decreasing workforce compel automation to be directed toward helping labs in repetitive and precise work.
Read More
One and Only
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MoreDiagnoCure PCA3 Test Presented at European Association of Urology Meeting
DiagnoCure Inc announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology (EAU) meeting,
Read MorePROGENSA PCA3 Assay Can Help Predict Outcome of Initial Prostate Biopsies
Gen-Probe’s PROGENSA PCA3 assay can help predict the outcome of initial prostate biopsies in men suspected of having prostate cancer, according to a study of the molecular urine test presented in a scientific poster last week.
Read More